South Africa Seeks New Vaccine Strategy After Study
Researchers determined the AstraZeneca vaccine is not as effective against certain cases of a variant first discovered in the country.
The rollout of AstraZeneca's COVID vaccine in South Africa is being put on hold.
This comes after researchers determined it's not as effective against certain cases of a variant first discovered in the country.
The study, which hasn't been released yet, found the vaccine "provides minimal protection" against mild and moderate cases of this variant.
Severe cases were not studied.
The company says it's working with South African leaders to figure out a way to proceed.
In the meantime, South Africa is moving forward with Johnson & Johnson and Pfizer's vaccines.
Moderna defends vax price hike, despite billions in taxpayer funding
The company is planning to raise the price of its COVID-19 vaccine from about $26 per dose up to $130 per dose.
What living with long COVID is really like
Scripps News talked to a dozen people with long-term COVID symptoms about their current experience and their hope for the future.
New data links COVID-19 pandemic's origins to raccoon dogs
The discovery does not prove that raccoon dogs or any other animals infected with COVID triggered the pandemic.
Are video games contributing to gambling problems?
Experts say the legalization of gambling, especially in mobile settings, is leading to a blurrier line between that and video games.
Ukrainian mom's visit to the US turned into a mission to help refugees
What started as visit to her son in Chicago is now a mission to help other Ukrainian refugees settle in the Windy City.
Woman sues artificial tears maker after loss of eyeball
Ezricare's artificial tears have been linked to a bacterial infection that is causing blindness, loss of eyes and even death.